Five-year follow-up study of stage I-IV rectal cancer including EGFR immunoexpression and p21 immunoactivity
Saved in:
Main Authors: | Monika Kozłowska-Geller, Stanisław Głuszek, Piotr Lewitowicz |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2021-03-01
|
Series: | Gastroenterology Review |
Subjects: | |
Online Access: | https://www.termedia.pl/Five-year-follow-up-study-of-stage-I-IV-rectal-cancer-r-nincluding-EGFR-immunoexpression-r-nand-p21-immunoactivity,41,43700,1,1.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EGFR inhibitors in the treatment of colorectal cancer
by: M. В. Zabelin, et al.
Published: (2018-09-01) -
A combined diagnostic model including middle rectal artery visualization for predicting lateral lymph node metastasis in rectal cancer
by: Ning Wang, et al.
Published: (2025-01-01) -
The patient perspective on transanal irrigation treatment for low anterior resection syndrome after rectal cancer surgery - a qualitative and quantitative study
by: Boglarka Rethy, et al.
Published: (2025-02-01) -
Efficacy and Safety of Chemotherapy or EGFR‐TKIs as First‐Line Therapy in NSCLC Patients Harboring Non‐Ex 20 Ins Uncommon EGFR Mutations: A Retrospective Study in China
by: Chen Liao, et al.
Published: (2025-01-01) -
Afatinib and Necitumumab in EGFR-Mutant NSCLC with Acquired Resistance to Tyrosine Kinase Inhibitors
by: Nathaniel J. Myall, MD, et al.
Published: (2025-02-01)